Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers

Nusrat Khan1, Keiko Akagi1, Shiming Jiang1

  • 1Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Discovery
|May 13, 2025
PubMed

Insights

Human papillomavirus (HPV) integration can cause gene fusions, like FGFR3-TACC3, which, along with HPV oncoproteins, drive oropharyngeal cancer development. This highlights a key mechanism in HPV-driven carcinogenesis.

Area of Science:

  • Oncology
  • Genomics
  • Virology

Background:

  • Human papillomavirus (HPV) integration into the host genome disrupts cellular processes, but its direct role in cancer development is not fully understood.
  • Genomic alterations and gene fusions adjacent to HPV integration sites have been observed in oropharyngeal cancers.

Purpose of the Study:

  • To investigate whether HPV integration-induced host gene fusions contribute to cancer development.
  • To elucidate the molecular mechanisms by which HPV oncoproteins and host gene fusions interact to promote tumorigenesis.

Main Methods:

  • Genomic analyses of oropharyngeal cancers to identify host fusion genes.
  • Evolutionary modeling to understand the origins of fusion gene formation.
  • Mouse models (xenograft and syngeneic) to assess the oncogenic potential of HPV oncoproteins and FGFR3-TACC3.
  • Analysis of oncoprotein stability and transcriptional changes.

Main Results:

  • Recurrent FGFR3-TACC3 fusions were identified adjacent to HPV integration sites in oropharyngeal cancers.
  • Integration of viral concatemers was implicated as an initiating event in fusion formation.
  • Co-expression of HPV16 E6/E7 oncoproteins and FGFR3-TACC3, but not individually, was sufficient for tumor development in mouse models.
  • FGFR3-TACC3 expression stabilized HPV oncoproteins by reducing their degradation, increasing their abundance.
  • Tumorigenesis was associated with unique transcriptional programs.

Conclusions:

  • HPV integration leading to host gene fusions, such as FGFR3-TACC3, plays a significant role in oropharyngeal cancer development.
  • The combined expression of HPV oncoproteins and specific host gene fusions is sufficient to initiate and drive cancer.
  • Understanding these mechanisms provides insights into HPV-driven carcinogenesis and potential therapeutic targets.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
4.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
4.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.1K